空気圧式ネブライザーの市場規模、シェア、成長分析：適応症別、最終用途別、地域別 - 産業予測 2025～2032年

空気圧式ネブライザー市場規模は2023年に8億405万米ドルとなり、予測期間（2025～2032年）のCAGRは6.7%で、2024年の8億5,792万米ドルから2032年には14億4,133万米ドルに成長する見通しです。

空気圧式ネブライザー市場は、医療機器産業の重要な構成要素であり、患者の呼吸ケアのニーズに応えることに重点を置いています。これらのデバイスは、液体の薬剤を吸入用の微細なミストに変換し、喘息やCOPDなどの呼吸器疾患に対する治療の効果的な送達を強化します。こうした疾患の罹患率の増加、人口の高齢化、呼吸器の健康管理に関する意識の高まりにより、市場は着実な成長を遂げています。また、技術の進歩により携帯型で使いやすいネブライザーが登場し、需要をさらに押し上げています。北米と欧州が市場をリードしていますが、アジア太平洋地域は大気汚染とヘルスケア投資の増加により急速に拡大しています。フィリップス・レスピロニクスやオムロンヘルスケアなどの主要企業は、患者の快適性と薬物送達を改善するために技術革新を行っており、市場の継続的な成長を確実なものにしています。

目次

イントロダクション

• 調査の目的
• 調査範囲
• 定義

調査手法

• 情報調達
• 二次と一次データの方法
• 市場規模予測
• 市場の前提条件と制限

エグゼクティブサマリー

• 世界市場の見通し
• 供給と需要の動向分析
• セグメント別機会分析

市場力学と見通し

• 市場概要
• 市場規模
• 市場力学
  • 促進要因と機会
  • 抑制要因と課題
• ポーターの分析

主な市場の考察

• 重要成功要因
• 競合の程度
• 主な投資機会
• 市場エコシステム
• 市場の魅力指数（2024年）
• PESTEL分析
• マクロ経済指標
• バリューチェーン分析
• 価格分析
• ケーススタディ
• 規制情勢
• 特許分析

空気圧式ネブライザー市場規模：適応症別

• 市場概要
• 呼吸作動型
• 通気型

空気圧式ネブライザー市場規模：最終用途別

• 市場概要
• 病院・クリニック
• 在宅ヘルスケア

空気圧式ネブライザー市場規模

• 北米
  • 米国
  • カナダ
• 欧州
  • ドイツ
  • スペイン
  • フランス
  • 英国
  • イタリア
  • その他欧州地域
• アジア太平洋地域
  • 中国
  • インド
  • 日本
  • 韓国
  • その他アジア太平洋地域
• ラテンアメリカ
  • ブラジル
  • その他ラテンアメリカ地域
• 中東・アフリカ
  • GCC諸国
  • 南アフリカ
  • その他中東・アフリカ

競合情報

• 上位5社の比較
• 主要企業の市場ポジショニング（2024年）
• 主な市場企業が採用した戦略
• 最近の市場動向
• 企業の市場シェア分析（2024年）
• 主要企業の企業プロファイル
  • 企業の詳細
  • 製品ポートフォリオ分析
  • 企業のセグメント別シェア分析
  • 収益の前年比比較（2022～2024年）

主要企業プロファイル

• Philips Healthcare（Netherlands）
• Omron Healthcare, Inc.（Japan）
• PARI GmbH（Germany）
• Drive DeVilbiss Healthcare（USA）
• Medline Industries, Inc.（USA）
• Invacare Corporation（USA）
• GF Health Products, Inc.（USA）
• Briggs Healthcare（USA）
• Allied Healthcare Products, Inc.（USA）
• Aerogen（Ireland）
• Trudell Medical International（Canada）
• Salter Labs（USA）
• Vyaire Medical, Inc.（USA）
• Besco Medical Co., Ltd.（China）
• Rossmax International Ltd.（Taiwan）
• Microlife Corporation（Taiwan）
• Becton, Dickinson and Company（USA）
• Teleflex Incorporated（USA）
• Agilent Technologies, Inc.（USA）
• ResMed Inc.（USA）

結論と提言

Pneumatic Nebulizers Market size was valued at USD 804.05 million in 2023 and is poised to grow from USD 857.92 million in 2024 to USD 1441.33 million by 2032, growing at a CAGR of 6.7% during the forecast period (2025-2032).

The pneumatic nebulizers market is a vital component of the medical devices industry, focused on meeting the respiratory care needs of patients. These devices transform liquid medications into a fine mist for inhalation, enhancing the effective delivery of treatments for respiratory conditions like asthma and COPD. The market is experiencing steady growth due to the increasing incidence of such diseases, an aging population, and heightened awareness regarding respiratory health management. Technological advancements have also led to the emergence of portable and user-friendly nebulizers, further driving demand. North America and Europe lead the market, while the Asia-Pacific region is rapidly expanding due to rising air pollution and healthcare investments. Key players, including Philips Respironics and Omron Healthcare, are innovating to improve patient comfort and medication delivery, ensuring the market's continued growth.

Top-down and bottom-up approaches were used to estimate and validate the size of the Pneumatic Nebulizers market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Pneumatic Nebulizers Market Segments Analysis

Global Pneumatic Nebulizers Market is segmented by Indication, End Use and region. Based on Indication, the market is segmented into Breath-Actuated and Vented. Based on End Use, the market is segmented into Hospitals & Clinics and Home Healthcare. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Pneumatic Nebulizers Market

The rising incidence of respiratory ailments such as asthma, chronic obstructive pulmonary disease (COPD), and cystic fibrosis significantly propels the growth of the pneumatic nebulizers market. As these conditions demand efficient medication administration directly to the lungs to aid in symptom relief and disease management, there is an escalating need for advanced nebulizer systems. This trend highlights the vital role pneumatic nebulizers play in providing effective therapy for patients suffering from these chronic respiratory illnesses, thereby driving further innovation and investment in this market segment to meet the growing healthcare demands and improve patient outcomes.

Restraints in the Pneumatic Nebulizers Market

The Pneumatic Nebulizers market encounters significant restraints due to the competition posed by alternative respiratory therapies like inhalers and dry powder inhalers. These alternative devices offer convenience, portability, and ease of use, potentially making them more appealing to patients and healthcare providers. As these options continue to gain popularity, they may hinder the growth of the Pneumatic Nebulizers market. Additionally, advancements in inhaler technology and the increasing emphasis on patient-centric treatment approaches can further challenge the market's expansion. Consequently, the presence of these alternative therapies necessitates a strategic response from Pneumatic Nebulizer manufacturers to maintain their market share.

Market Trends of the Pneumatic Nebulizers Market

The pneumatic nebulizers market is experiencing significant growth driven by notable technological advancements that enhance device efficiency and user experience. Innovations such as quieter operation, accelerated drug delivery times, and optimized particle size distribution are becoming increasingly prevalent, facilitating better therapeutic outcomes for respiratory patients. Manufacturers are focusing on user-friendly designs that cater to diverse patient needs, thereby boosting adoption rates among both healthcare professionals and consumers. As awareness of respiratory conditions grows and the demand for effective treatment solutions increases, the pneumatic nebulizers market is positioned for robust expansion, reflecting broader trends towards improved patient-centric healthcare devices.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Case Studies
• Regulatory Landscape
• Patent Analysis

Global Pneumatic Nebulizers Market Size by Indication & CAGR (2025-2032)

• Market Overview
• Breath-Actuated
• Vented

Global Pneumatic Nebulizers Market Size by End Use & CAGR (2025-2032)

• Market Overview
• Hospitals & Clinics
• Home Healthcare

Global Pneumatic Nebulizers Market Size & CAGR (2025-2032)

• North America (Indication, End Use)
  • US
  • Canada
• Europe (Indication, End Use)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Indication, End Use)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Indication, End Use)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Indication, End Use)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Philips Healthcare (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Omron Healthcare, Inc. (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PARI GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Drive DeVilbiss Healthcare (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medline Industries, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Invacare Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GF Health Products, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Briggs Healthcare (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Allied Healthcare Products, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Aerogen (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Trudell Medical International (Canada)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Salter Labs (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Vyaire Medical, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Besco Medical Co., Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Rossmax International Ltd. (Taiwan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Microlife Corporation (Taiwan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Becton, Dickinson and Company (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Teleflex Incorporated (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Agilent Technologies, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ResMed Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations